Analiz Rodriguez

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI High Impact

Associate Professor

University of Arkansas UAMS primary UA Little Rock

Also affiliated: Kanazawa University (2020); Atrium Health Wake Forest Baptist (2014–2016); City Of Hope National Medical Center (2017–2022); Los Alamos National Laboratory (2004); University of Idaho (2007); University of Arkansas Medical Center (2019–2024); New College of Florida (2004); City of Hope (2017–2022); Neurological Surgery (2020); Arkansas Department of Health (2020); Beckman Research Institute (2022); Wake Forest University Health Sciences (2014–2017); Wake Forest University (2014–2017); University of Colorado Anschutz (2017); Case Western Reserve University (2007–2009); Stony Brook University (2020); Icahn School of Medicine at Mount Sinai (2017)

Neurosurgery, College of Medicine

26 h-index 182 pubs 8,029 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website UAMS TRI Profile

OverviewAI-generated summary

Analiz Rodriguez, an Associate Professor in Neurosurgery at the University of Arkansas for Medical Sciences, studies advancements in cancer treatment and neurosurgery. Her research has focused on novel therapeutic approaches for glioblastoma, including the use of oncolytic viruses and CAR T-cell therapy. She has investigated the role of laser interstitial thermal therapy in managing high-grade gliomas and has been involved in a phase 1/2 trial for oncolytic virotherapy combined with immunotherapy for recurrent glioblastoma.

Rodriguez also leads research into the development of organoid models for cancer metastasis, receiving $76,500 from the NIH/National Cancer Institute for the development of immunocompetent melanoma brain metastases organoids. Her work extends to understanding the challenges and clinical applications of CAR-T therapies in solid tumors. Additionally, her scholarly contributions include analyses of neurosurgery resident enrollment and attrition, with a focus on the career paths of women in the field.

With an h-index of 26 and over 8,000 citations from 184 publications, Rodriguez is recognized as a highly cited researcher. She actively collaborates with colleagues at the University of Arkansas for Medical Sciences, including Murat Gökden, Megan R. Reed, Annick De Loose, and Robert L. Eoff, with whom she shares multiple publications.

Metrics

h-index: 26
Publications: 182
Citations: 8,029

Positions

Associate Professor 2022–present

University of Arkansas for Medical Sciences Neurosurgery, College of Medicine Institutional directory
Director of Neurosurgical Oncology 2017–present

University of Arkansas for Medical Sciences Department of Neurosurgery ORCID
Assistant Professor 2017–2022

University of Arkansas for Medical Sciences Department of Neurosurgery ORCID
Instructor 2016–2017

City Of Hope National Medical Center Neurosurgical Oncology ORCID
Intern 2009–2010

University of Pittsburgh Medical Center General Surgery ORCID
Medical Scientist Trainee 2003–2009

US National Institutes of Health Medical Scientist Training Program ORCID

Selected Publications

Longitudinal multi-omics characterization of the malignant evolution in multirelapsing glioblastoma (2026)

medRxiv DOI OpenAlex
Long-read sequencing for cancer liquid biopsy: advancing precision oncology (2026)

Frontiers in Oncology 1 citation DOI OpenAlex
Endoscopic transsphenoidal resection of large sellar chondrosarcoma compressing the optic nerve: illustrative case (2026)

Journal of Neurosurgery Case Lessons DOI OpenAlex
Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation (2026)

Life Science Alliance 2 citations DOI OpenAlex
Impact of baseline brain metastases on survival and CNS progression in NSCLC patients treated with immune checkpoint inhibitors in real-world studies: a systematic review and meta-analysis (2026)

Translational Lung Cancer Research DOI OpenAlex
Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study (2026)

Journal of Clinical Oncology DOI OpenAlex
ANGI-14. GLIOBLASTOMA PROGRESSION FROM TRANSCRIPTOMIC REGULATION TO BRAIN FUNCTIONAL CONNECTIVITY (2025)

Neuro-Oncology DOI OpenAlex
RADT-51. SURGICALLY TARGETED RADIATION THERAPY (START) FOR PREVIOUSLY IRRADIATED RECURRENT BRAIN METASTASES: INITIAL REPORT FROM A MULTI-INSTITUTIONAL PROSPECTIVE STUDY (2025)

Neuro-Oncology DOI OpenAlex
Survival Outcomes of Immune Checkpoint Inhibitors in Conjunction with Cranial Radiation for Older Adults with Non-Small Cell Lung Cancer and Synchronous Brain Metastasis (2025)

Current Oncology DOI OpenAlex
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial (2025)

Nature Medicine 3 citations DOI OpenAlex
Interstitial Thermal Therapy in Mesial Temporal Lobe Epilepsy (2025)

JAMA Neurology 10 citations DOI OpenAlex
Navigating molecular neuropathology of CNS neoplasms for the practicing surgical pathologist (2025)

American Journal of Clinical Pathology DOI OpenAlex
Abstract 2645: Rnd3 depletion in lung cancer cell lines decreases cell invasion and migration in a ROCK1 independent manner (2025)

Cancer Research DOI OpenAlex
SURG-54. RECURRENT BRAIN METASTASES (RBM) TREATED WITH SURGICALLY TARGETED RADIATION THERAPY (START): PRELIMINARY SAFETY EVALUATION FROM A MULTI-INSTITUTIONAL PROSPECTIVE REGISTRY (2024)

Neuro-Oncology DOI OpenAlex
Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyond (2024)

Frontiers in Oncology 5 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $76,500 total

NIH Contact PI Mar 2024 - Feb 2026

Development of immunocompetent melanoma brain metastases organoids

National Cancer Institute $76,500 R03

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

A Phase IlI Clinical Trial Evaluating DCVax-L, Autologous Dendritis Cells Pulsed Northwest Biotherapeutics, Inc. Principal Investigator
Photobiomodulation to Ameliorate Neuronal Degeneration and Cognitive Decline after Mixed Field Irradiation - Continuation National Aeronautics & Space Administration Co-Investigator
Center for Studies of Host Response to Cancer Therapy NIH Co-Investigator
Novel Platform linking cancer-specific glycosylation with cell signaling outcomes NIH Co-Investigator